Navigation Links
Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
Date:12/22/2011

CAMBRIDGE, Mass., Dec. 22, 2011 /PRNewswire/ -- Inspiration Biopharmaceuticals, Inc. (Inspiration), the only biopharmaceutical company focused exclusively on the development and commercialization of new treatment options for people with hemophilia, announced today the Company will relocate its corporate headquarters to Cambridge, MA from Laguna Niguel, CA.  The move is integral to Inspiration's plan to accommodate its anticipated future staffing and facility needs as the Company transitions to product commercialization.

Inspiration's new location at One Kendall Square is ideally located within the greater Boston area's technology and life sciences cluster.  The new address is:

Inspiration Biopharmaceuticals
One Kendall Square
Cambridge, MA 02139

John P. Butler, Chief Executive Officer of Inspiration, commented, "The Boston metro area has always been a center for growth and innovation in the biopharmaceutical industry.  As we move toward the launch of Inspiration's first products, including IB1001, our recombinant factor IX product for hemophilia B, it is the perfect location to establish our corporate office.  We expect the close proximity to some of the leading academic and research institutions will help attract top talent as we continue to build a world-class company focused on improving the life of individuals with hemophilia."

In October 2011, Inspiration named John P. Butler Chief Executive Officer.  Mr. Butler joined Inspiration from Cambridge-based Genzyme Corporation, where he most recently served as President of the company's rare genetic diseases business.

One Kendall Square is in the heart of Cambridge's life-sciences community.  Since its inception, this address has served as headquarters for many early-stage to mid-tier companies, including a number that have gone on to develop blockbuster drugs and employ thousands of workers in Greater Boston.  The office and res
'/>"/>

SOURCE Inspiration Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Inspiration Biopharmaceuticals Announces Acceptance of European Marketing Authorization Application for IB1001 for the Treatment of Hemophilia B
2. Using magnetic toys as inspiration, researchers tease out structures of self-assembled clusters
3. Inspiration Biopharmaceuticals Presents Safety Data on IB1001, a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Society on Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
5. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in Zerenex™ (Ferric Citrate) Phase 3 Long-Term Study
6. Planet Biopharmaceuticals, Inc. Appoints Theron (Ted) Odlaug, Ph.D. as Executive Chairman
7. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in KRX-0401 (Perifosine) Phase 3 Refractory Advanced Colorectal Cancer Study
8. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2011 Financial Results
9. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2011 Financial Results
10. Keryx Biopharmaceuticals Announces Positive Final Data from Zerenex™ Short-Term Phase 3 Study
11. Reportlinker Adds Upstream Processing in Biopharmaceuticals - Increasing Use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Pipette.com has added the ... their comprehensive portfolio of Eppendorf products. , The Eppendorf ... a Centrifuge 5424/5424 R and receive the following:, ... Research plus or Eppendorf Reference 2 , ...
(Date:1/22/2015)... Selexis SA, a serial innovation company ... (RCBs) used for drug discovery to commercial manufacturing, announced ... Next-Generation Sequencing (NGS) data packages. The NGS ... by ensuring the integrity of the gene, validation of ...
(Date:1/22/2015)... , Jan. 22. 2015  Varian Medical Systems (NYSE: ... been honored for its commitment to sustainability with inclusion on ... is the highest ranked healthcare equipment company among the Corporate ... the World Economic Forum at Davos, Switzerland ...
(Date:12/24/2014)... 24, 2014  United Therapeutics Corporation (NASDAQ: UTHR ... MDT ) has submitted a pre-market approval application to ... use of Medtronic,s SynchroMed ® II implantable drug ... with United Therapeutics, Remodulin ® (treprostinil) Injection delivered ...
Breaking Biology Technology:Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... Genoptix, Inc.,(Nasdaq: GXDX ), a specialized laboratory ... BIOCOM Investor Conference 2008,scheduled to take place at ... October,26-28, 2008., Dr. Tina Nova, President and ... Monday, October 27, beginning at approximately 9:30 a.m. ...
... Days Faster Test Results Enable Physicians to Direct Earlier, Effective, ... ... Infections and Save Lives(1), WOBURN, Mass., Oct. 22 ... AdvanDx,s PNA FISH(TM) test reduced,mortality by 42% for patients with ...
... or the "Company") (Nasdaq and MTA: CTIC) today ... $24.7 million, newly,issued 9.66% Convertible Senior Notes due ... The new Notes would have a $24.7 ... entitling the holder, upon any conversion of,the Notes, ...
Cached Biology Technology:Genoptix Announces Participation at the BIOCOM Investor Conference 2008 2AdvanDx's PNA FISH(TM) Test Shown to Reduce Mortality by 42% for Patients With Hospital-Acquired Enterococcus faecium Bloodstream Infections 2AdvanDx's PNA FISH(TM) Test Shown to Reduce Mortality by 42% for Patients With Hospital-Acquired Enterococcus faecium Bloodstream Infections 3AdvanDx's PNA FISH(TM) Test Shown to Reduce Mortality by 42% for Patients With Hospital-Acquired Enterococcus faecium Bloodstream Infections 4AdvanDx's PNA FISH(TM) Test Shown to Reduce Mortality by 42% for Patients With Hospital-Acquired Enterococcus faecium Bloodstream Infections 5Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $24.7 Million of Senior Convertible Notes 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $24.7 Million of Senior Convertible Notes 3
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... the "Global Chemical Sensor Market 2015-2019" report ... One major trend upcoming in this ... biomedical applications. Chemical sensors help in recording of patient ...
(Date:12/11/2014)... 2014 Research and Markets , ... has announced the addition of the "Biometrics Market ... One major trend emerging in this market ... systems utilize more than one characteristic of an individual ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... How do viruses get into cells? In pursuing this central ... 1997, and his team have pioneered research in this field. ... Swiss Nobel Prize in Bern, Switzerland. This award is not ... a confirmation of our long years of work, and demonstration ...
... academic entrepreneurs has teamed up with the University ... in membrane biology to pharmaceutical, biotech and agrochemical ... spin-out company Oxford Molecular into a business worth ... for Integrative Membrane Biology (CIMB) to broker research ...
... 24 years ago in Montana has,finally been identified ... Asian dinosaurs. The dinosaur would have weighed 30 to ... feet tall. The fossil,came from sediment that,s about 80 ... was published in September,s issue of the Journal,of Vertebrate ...
Cached Biology News:ETH Zurich professor Ari Helenius awarded Benoist Prize 2New partnership offers outsourced R&D in membrane biology 2New dinosaur species found in Montana 2
...
... Immunogen: Synthetic peptide derived from ... rat mouse dog and orangutang occludin ... human occludin protein. Reactivity: Human ... Reactivity with rat mouse dog and ...
...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
Biology Products: